Topic: Sanofi-Aventis SA
Genzyme Corporation (Cambridge, MA) has reported that production of its Gaucher treatment, Cerezyme is now up to historical averages and they began...
Is Pfizer (NYSE: PFE) folding on making acquisition deals? That seems to be a trick question as the drug giant announced the purchase of FoldRx...
We'd all like to invest as successfully as the legendary Warren Buffett. He calculates return on invested capital (ROIC) to help determine whether...
Stocks fell Monday after more signs of slowing economic growth got investors worried ahead of a key report on jobs later this week.. . The Dow...
Henri Termeer, the longtime chief executive of Genzyme Corp., announced yesterday that there's a "high probability" Sanofi-Aventis will buy his ...
By Meg Tirrell and Elizabeth Lopatto . Sept. 1 (Bloomberg) -- Henri Termeer, a biotech industry pioneer and chief executive officer at Genzyme...
Nothing like a temperature reading to assess a situation, and Genzyme ceo Henri Termeer confronts an inevitable takeover by Sanofi-Aventis, at...
"Let me in, and I might go higher." That, in a nutshell, is the message Chris Viehbacher, the chief executive of Sanofi-Aventis, is sending the...
"The Genzyme board is not prepared to engage in merger negotiations with Sanofi based on an opportunistic proposal with an unrealistic starting...
Sanofi-Aventis, the French drug maker, publicly disclosed its $18.5 billion bid for Genzyme on Sunday, intensifying pressure on the American...